Clinical Trial Update: Study of Plozasiran (ARO-APOC3) in Adults With Severe Hypertriglyceridemia [Phase 3]

View source ↗

Summary

Phase 3 trial of Plozasiran (ARO-APOC3) in adults with severe hypertriglyceridemia is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertriglyceridemia

Drugs mentioned

• Plozasiran

Snippet

Sponsor: Arrowhead Pharmaceuticals | Conditions: Severe Hypertriglyceridemia | Phase 3 | Status: ACTIVE_NOT_RECRUITING